← Leaderboards
Ernst Schonbrunn
University Of Kansas Medical Center
$3,070,192
Attributed
$4,134,318
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $871.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,134,318 · 9
By mechanism
R01$2,609,481 · 2
P20$871,126 · 4
R21$433,255 · 1
R03$142,308 · 1
U19$78,148 · 1
Top collaborators
- Justin Matthew Lopchuk4 shared
- Jiandong Chen2 shared
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Christophe P Nicot$8,402,462
- Edward Brice Stephens$8,642,647
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignMutantProteinsResearch PersonnelComplexGrowthStructurePropertyLaboratoriesAntibioticsBacteriaTransferaseProteomicsX Ray CrystallographyStructure-Activity RelationshipLigandsSiteCrystallographyDrug DesignInnovationCommunitiesAnalogBaseCombat
Grant awards (21)
Selective targeting of TAF1 function in acute myeloid leukemia$635,624
R01 · FY2025 · CA · contact PI
Development of bifunctional CDK2 inhibitors for treatment of CCNE1-driven cancers$196,934
R21 · FY2025 · CA · contact PI
Selective targeting of TAF1 function in acute myeloid leukemia$635,624
R01 · FY2024 · CA · contact PI
Development of bifunctional CDK2 inhibitors for treatment of CCNE1-driven cancers$236,321
R21 · FY2024 · CA · contact PI
Structure-activity analysis of enolpyruvyl transferases$284,597
R01 · FY2009 · GM · contact PI
Structural Biology Core$78,148
U19 · FY2009 · CA · contact PI
Structure-activity analysis of enolpyruvyl transferases$283,317
R01 · FY2008 · GM · contact PI
COBRE: UKS: CORE B: HIGH THROUGHPUT SCREENING & TARGET IDENTIFICATION$213,846
P20 · FY2007 · RR · contact PI
Structure-activity analysis of enolpyruvyl transferases$175,455
R01 · FY2007 · GM · contact PI
Structure-activity analysis of enolpyruvyl transferases$82,555
R01 · FY2007 · GM · contact PI
Structure-activity analysis of enolpyruvyl transferases$253,109
R01 · FY2006 · GM · contact PI
Characterization of novel MurA inhibitors$70,308
R03 · FY2006 · AI · contact PI
Structure-activity analysis of enolpyruvyl transferases$259,200
R01 · FY2005 · GM
MOLECULAR MODE OF ACTION OF NOVEL MURA INHIBITORS$72,904
P20 · FY2005 · RR
Characterization of novel MurA inhibitors$72,000
R03 · FY2005 · AI
COBRE KS: XRAY CRYSTALLOGRAPHY CORE (JULY 1-DECEMBER 31, 2004)$71,509
P20 · FY2005 · RR
COBRE KS: STRUCT FUNCTN RELATIONSHIP OF ANTIBIOTIC TARGETS MURA &EPSP SYNTHASE$287,987
P20 · FY2004 · RR
CORE--COBRE KS: XRAY CRYSTALLOGRAPHY$224,880
P20 · FY2004 · RR
STRUCTURE/FUNCTION RELATIONSHIP OF ANTIBIOTIC TARGETS$0
P20 · FY2002 · RR
Core--Protein structure laboratory$0
P20 · FY2002 · RR
STRUCTURE/FUNCTION RELATIONSHIP OF ANTIBIOTIC TARGETS$0
P20 · FY2001 · RR